BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, He Y, Zhu J, Pang H, Lin Y, Zheng J. Apatinib-based targeted therapy against pulmonary sarcomatoid carcinoma: a case report and literature review. Oncotarget 2018;9:33734-8. [PMID: 30263099 DOI: 10.18632/oncotarget.25989] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Zheng Y, Fu Y, Zhong Q, Deng R, Zhang Y. The treatment of advanced pulmonary sarcomatoid carcinoma. Future Oncol 2021. [PMID: 34879738 DOI: 10.2217/fon-2021-1071] [Reference Citation Analysis]
2 Zhang L, Lin W, Yang Z, Li R, Gao Y, He J, Cui Q. Multimodality Treatment of Pulmonary Sarcomatoid Carcinoma: A Review of Current State of Art. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/8541157] [Reference Citation Analysis]
3 Suster DI, Mino-Kenudson M. Molecular Pathology of Primary Non-small Cell Lung Cancer. Arch Med Res 2020;51:784-98. [PMID: 32873398 DOI: 10.1016/j.arcmed.2020.08.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Li X, Wu D, Liu H, Chen J. Pulmonary sarcomatoid carcinoma: progress, treatment and expectations. Ther Adv Med Oncol 2020;12:1758835920950207. [PMID: 32922522 DOI: 10.1177/1758835920950207] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Ding K, Chen X, Li Y, Li W, Ye Y, He T, Wang W, Zhang H. Gastric Cancer Harboring an ERBB3 Mutation Treated with a Pyrotinib-Irinotecan Combo: A Case Study. Onco Targets Ther 2021;14:545-50. [PMID: 33500629 DOI: 10.2147/OTT.S286024] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]